Funder
National Institutes of Health
American Foundation for Pharmaceutical Education
National Center for Advancing Translational Sciences
Reference21 articles.
1. QSAR modeling of SARS-CoV Mpro inhibitors identifies sufugolix, cenicriviroc, proglumetacin, and other drugs as candidates for repurposing against SARS-CoV-2;Alves;Mol Inform,2021
2. Novel antiviral activities of obatoclax, emetine, niclosamide, brequinar, and homoharringtonine;Andersen;Viruses 2019,2019
3. Learning from history: do not flatten the curve of antiviral research;Bobrowski;Drug Discov. Today,2020
4. Synergistic and antagonistic drug combinations against SARS-CoV-2;Bobrowski;Mol. Ther.,2021
5. Compound Curation Pipeline,2020
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献